Literature DB >> 29990604

Factors of Delayed Hyperperfusion and the Importance of Repeated Cerebral Blood Flow Evaluation for Hyperperfusion After Direct Bypass for Moyamoya Disease.

Shunsuke Nomura1, Koji Yamaguchi2, Tatsuya Ishikawa1, Akitsugu Kawashima3, Yoshikazu Okada1, Takakazu Kawamata1.   

Abstract

OBJECTIVE: Postoperative hyperperfusion is an important complication after direct bypass for moyamoya disease, which sometimes occurs late after initial postoperative cerebral blood flow (CBF) measurement. This study aimed to clarify the incidence of hyperperfusion with management using postoperative continuous sedation and repeated postoperative CBF measurement and to identify factors associated with delayed hyperperfusion.
METHODS: This retrospective study evaluated 72 consecutive hemispheres in 56 adult Japanese patients with moyamoya disease who underwent direct bypass. Postoperative continuous sedation was routinely administered based on CBF evaluation. First, the incidence of symptomatic hyperperfusion was investigated. Second, radiologic hyperperfusion (RHP), which was strictly defined as >30% increase in CBF compared with the contralateral side, and factors associated with delayed RHP were statistically analyzed.
RESULTS: Postoperative symptomatic hyperperfusion occurred in 3 hemispheres (4.2%), including subarachnoid hemorrhage in 1 hemisphere (1.4%). RHP immediately after surgery was identified in 16 hemispheres (22.2%). In 8 hemispheres (11.1%), RHP appeared or worsened several days after initial CBF study. In univariate logistic regression analysis, decreased preoperative cerebral vasoreactivity was significantly associated with delayed RHP.
CONCLUSIONS: The incidence of symptomatic hyperperfusion was 4.2% with management. Delayed hyperperfusion was significantly associated with decreased cerebral vasoreactivity. Therefore, repeated CBF measurements evaluating preoperative cerebral vasoreactivity may decrease complications.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral blood flow; Hyperperfusion; Moyamoya disease; Sedation

Mesh:

Year:  2018        PMID: 29990604     DOI: 10.1016/j.wneu.2018.06.218

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  2 in total

1.  Diagnosis and Management of Moyamoya Disease.

Authors:  Shinichiro Uchiyama; Masako Yamazaki; Tatsuya Ishikawa; Koji Yamaguchi; Takakazu Kawamata
Journal:  Case Rep Neurol       Date:  2020-12-14

2.  Measurement of Intraoperative Graft Flow Predicts Radiological Hyperperfusion during Bypass Surgery in Patients with Moyamoya Disease.

Authors:  Akikazu Nakamura; Akitsugu Kawashima; Shunsuke Nomura; Takakazu Kawamata
Journal:  Cerebrovasc Dis Extra       Date:  2020-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.